'Chads 2' presentation slideshows

701 views • 70 slides

?????????????

?????????????. ?????? ???. ?????????? CHADS 2. CHADS 2 criteria C ongestive heart failure H ypertension A ge ?75 yrs D iabetes mellitus S troke/transient ischaemic attack. Score 1 1 1 1 2. 0 1 2 3 4 5 6. CHADS 2 score. 0. 5. 10. 15. 20. 25. 30.

657 views • 41 slides

epccs.eu

www.epccs.eu. Diabetes and hypertension When does diagnosing heart arrythmias matter? Prof John Camm London, United Kingdom. MarketScan & Thomson Reuters Medicare databases, 2009 1. Olmsted County data, 2006 (assuming a continued increase in the AF incidence) 2.

353 views • 35 slides

465 views • 30 slides

Midyear Clinical Pearls 2012

Midyear Clinical Pearls 2012. Tips for Responding to Codes. IV drug administration during out of hospital cardiac arrest Randomized to ACLS drugs vs. no ACLS drugs ROSC (40% vs. 25%; p<0.001) Survival to hospital discharge (10.5% vs. 9.2%; p=0.61)

439 views • 22 slides

A Reduced Antithrombotic Regimen Recommended by Current Guidelines

A trial F ibrillation and I schemic events with R ivaroxaban in pati E nts with stable coronary artery disease. Rivaroxaban Monotherapy versus Combination Therapy in Patients with Atrial Fibrillation and Stable Coronary Artery Disease.

212 views • 21 slides

??? ????????? ??? ????????????? ??? ?????????

??? ????????? ??? ????????????? ??? ?????????. 66yr/F HPI Exertional dyspnea and edema of lower extremities for one month PE BP 162/98 mmHg, HR 100 bpm. Moderately distended jugular vein Fine crackles over lower lung fields. Enlarged heart boarder

524 views • 18 slides

Journal Club

Journal Club. Jim Hoehns, Pharm.D. Edoxaban. Oral factor Xa inhibitor Bioavailability: 62% Tmax : 1-2 hrs Elimination: 50% renal Half-life: 9-11 hours. ENGAGE AF-TIMI 48. Randomized, double-blind, double-dummy trial N=21,105 patients with Afib Median follow-up: 2.8 years

359 views • 18 slides

Results Table 1. Warfarin group: Risk Ratios adjusted for warfarin

PREDICTING STROKE IN ADULTS WITH NON-RHEUMATIC ATRIAL FIBRILLATION: SYSTEMATIC REVIEW OF VALIDATION OF CHADS 2 CLINICAL PREDICTION RULE (Preliminary results) Emma Wallace 1 , Claire Keogh 1 Ciara Dillon 1, 2 , Borislav D Dimitrov 1 , Tom Fahey 1

158 views • 1 slides